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Pesticides are used extensively throughout the
world. In the United States, > 18,000 products
are licensed for use, and annual use of pesticides
for crops, homes, schools, parks, and forests
exceeds 2 billion pounds [U.S. Environmental
Protection Agency (EPA) 2002]. Neurologic
dysfunction is the best-documented health
effect of pesticide exposure. High-level expo-
sure has both acute and long-term neurologic
effects, and adverse effects have been reported
for most types of pesticides, including organo-
phosphate, carbamate, organochlorine, and
pyrethroid insecticides, herbicides, fungicides,
and fumigants. Organophosphates have been
studied in greatest detail. Acute organophos-
phate poisoning can involve a wide range of
both central and peripheral neurologic symp-
toms (Ecobichon 1996; Keifer and Mahurin
1997). Effects of organophosphate poisoning
may persist long after the acute response
is resolved; sequelae include increased neuro-
logic symptoms, deficits in neurobehavioral
performance, decreased vibration sensitivity,
and impaired nerve conduction (Kamel and
Hoppin 2004). Effects continue up to 10 years
after poisoning (Savage et al. 1988), suggesting
permanent residual damage. Even less severe
poisoning can have long-term consequences
(Wesseling et al. 2002).
Questions remain concerning the neuro-
logic effects of moderate pesticide exposure.
Most studies show effects on cognitive and
psychomotor neurobehavioral function in
chronically exposed individuals without a his-
tory of poisoning, although clinical measures
of peripheral nerve function like vibration sen-
sitivity and nerve conduction are not generally
affected (Kamel and Hoppin 2004). Increases
in both central and peripheral neurologic
symptoms are also found in many studies of
moderate exposure (Kamel and Hoppin
2004). Increased symptom prevalence may
provide early evidence of neurologic dysfunc-
tion, before clinically measurable signs are
evident. Unresolved issues regarding the rela-
tionship of pesticide exposure to symptom
prevalence include the relative importance of
acute and chronic exposure, of pesticide poi-
soning or high-exposure events compared
with chronic moderate exposure, and of pesti-
cides other than organophosphates.
The Agricultural Health Study (AHS) is a
large cohort study of licensed pesticide appli-
cators and their spouses (Alavanja et al. 1996,
1999a). Questionnaires completed by appli-
cators at enrollment provided information on
neurologic symptoms during the prior year as
well as detailed information on lifetime pesti-
cide use and exposure. We used this infor-
mation for a cross-sectional analysis of the
relationship of symptoms to several measures
of pesticide exposure.
Materials and Methods
Population and questionnaires. The AHS
cohort was recruited in 1993–1997 (Alavanja
et al. 1996, 1999a). In Iowa and North
Carolina, licenses for restricted-use pesticides
must be renewed every 3 years. Individuals
applying for new or renewed licenses were
invited to enroll in the study. Approximately
52,400 private applicators (mostly farmers)
participated, 82% of those eligible. At enroll-
ment, participants completed a self-adminis-
tered questionnaire that collected information
on demographic characteristics, lifestyle,
medical history, and pesticide use. A supple-
mental questionnaire, completed at home by
44% of the enrolled private applicators, col-
lected additional information in these cate-
gories as well as information on neurologic
symptoms. Applicators who returned the sup-
plemental questionnaire were similar to those
who did not in most respects, including
prevalence of symptoms and pesticide expo-
sure (Tarone et al. 1997). Together the two
questionnaires collected information on fre-
quency and duration of use of 50 speciﬁc pes-
ticides as well as on high-pesticide-exposure
events, medical visits for pesticide-related ill-
ness, and pesticide poisoning. All information
on exposures and disease states was taken
from these self-reports. Symptom questions
were based on an established questionnaire,
Q16, previously used to evaluate effects of
occupational exposure to neurotoxicants
(Lundberg et al. 1997). The questionnaires
are available on the AHS website (AHS 2004);
the symptom questions are in section 8,
Medical History, in the Farmer Applicator
Questionnaire.
The present analysis was restricted to
applicators with complete information on
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Exposure to high levels of many pesticides has both acute and long-term neurologic consequences,
but little is known about the neurotoxicity of chronic exposure to moderate levels of pesticides. We
analyzed cross-sectional data from 18,782 white male licensed private pesticide applicators enrolled
in the Agricultural Health Study in 1993–1997. Applicators provided information on lifetime pes-
ticide use and 23 neurologic symptoms typically associated with pesticide intoxication. An indicator
of more symptoms (≥ 10 vs. < 10) during the year before enrollment was associated with cumula-
tive lifetime days of insecticide use: odds ratios (95% conﬁdence intervals) were 1.64 (1.36–1.97)
for 1–50 days, 1.89 (1.58–2.25) for 51–500 days, and 2.50 (2.00–3.13) for > 500 days, compared
with never users. A modest association for fumigants [> 50 days, 1.50 (1.24–1.81)] and weaker
relationships for herbicides [> 500 days, 1.32 (0.99–1.75)] and fungicides [> 50 days, 1.23
(1.00–1.50)] were observed. Pesticide use within the year before enrollment was not associated with
symptom count. Only associations with insecticides and fumigants persisted when all four pesticide
groups were examined simultaneously. Among chemical classes of insecticides, associations were
strongest for organophosphates and organochlorines. Associations with cumulative exposure per-
sisted after excluding individuals who had a history of pesticide poisoning or had experienced an
event involving high personal pesticide exposure. These results suggest that self-reported neurologic
symptoms are associated with cumulative exposure to moderate levels of fumigants and organo-
phosphate and organochlorine insecticides, regardless of recent exposure or history of poisoning.
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Research | Environmental Medicinesymptoms—89% of those who returned the
supplemental questionnaire. Applicators with
incomplete symptom information (n = 2,603)
were slightly older, less well educated, and
more likely to live in North Carolina, com-
pared with the analysis group, but the median
number of symptoms experienced at least once
was the same. Many of the excluded applica-
tors omitted information for only one or two
symptoms (n = 1,651, 63% of those excluded).
Including them in the analysis by imputing
either a positive or negative response for the
missing symptoms did not substantively
change results. To reduce heterogeneity, the
analysis was further restricted to white men
18–75 years of age, who comprised 92% of
those otherwise eligible. Characteristics of the
18,782 applicators included in the analysis are
presented in Table 1.
The institutional review boards of the
National Institutes of Health, the University
of Iowa (Iowa field station), and Battelle
(North Carolina field station) approved the
AHS. The study was explained to potential
participants, who indicated consent by
returning questionnaires.
Data analysis. Table 2 shows frequencies of
23 symptoms during the year before enroll-
ment, in the categories originally reported.
Most of our analyses focused on these symp-
toms as a group. We created two measures
reﬂecting the number of symptoms experienced
at least once in the year before enrollment: a
continuous variable, “number of symptoms”
[median (interquartile range) = 4 (1–8)], and a
dichotomous variable, “many symptoms,” that
compared the 20% of applicators who experi-
enced ≥ 10 symptoms (“cases”) with the
remaining 80% who experienced < 10 symp-
toms (“controls”). The distribution of number
of symptoms was not greatly affected by omit-
ting the two most common and nonspecific
symptoms, headache and fatigue. We also
considered the 23 symptoms individually,
dichotomizing the frequency of each symptom
so that 5–15% of the population was in the
positive (“case”) category (Table 2).
We considered several pesticide exposure
measures, listed in Table 3. Applicators
reported years of use of any pesticide (in ﬁve
categories) and days per year (in seven cate-
gories). We then calculated lifetime days of
use by multiplying duration (quantiﬁed as the
central value of the reported category for years
of use) by frequency (central value of the
reported category for days per year) and then
categorizing in quartiles. A high-exposure
event was one causing “unusually high per-
sonal exposure” (Alavanja et al. 1999b).
Internal exposure was deﬁned as inhalation or
ingestion of pesticide. Pesticides were catego-
rized by function or mode of use, as herbi-
cides, insecticides, fungicides, or fumigants
(Table 3). Insecticides were further catego-
rized by chemical class. Cumulative lifetime
days for pesticide groups were calculated by
multiplying duration by frequency of use for
each pesticide in the group, summing over all
pesticides in the group, and categorizing into
three or four levels. We further categorized
by whether or not any pesticides in the group
were used in the year before enrollment
(Table 3).
We analyzed the data using linear regres-
sion for number of symptoms and logistic
regression for the dichotomous outcomes.
Analyses were performed in SAS (version 8.2;
SAS Institute Inc., Cary, NC) using AHS
phase I data (Prerelease 9/02; AHS 2004).
We adjusted for age, state, education, smok-
ing, and alcohol use, with variables catego-
rized as in Table 1. Information on age and
state was available for all applicators. For
applicators (< 3%) who were missing data on
education, cigarette smoking, or alcohol use,
we imputed the median value for their state
and age category. All outcome measures had
similar relationships to covariates. Final mod-
els included two-way interactions for age ×
state, age × education, age × smoking, age ×
drinking, state × education, state × smoking,
and state × drinking.
Results
In multivariate analyses, symptom prevalence
was greater among applicators who were from
Iowa, had more than a high school education,
smoked more, and drank more. There was a
strong monotonic inverse association of symp-
toms with age: Applicators 66–75 years of age
had 2.2 fewer symptoms and were half as likely
to have ≥ 10 symptoms than did applicators
18–30 years of age.
Both measures of symptom count—having
many (≥ 10) symptoms and total number of
symptoms—were associated with overall pesti-
cide use (Table 3). Applicators in the highest
quartile of lifetime days of pesticide use were
1.2 times as likely to experience ≥ 10 symp-
toms and averaged 0.6 more symptoms in the
year preceding enrollment, compared with the
Kamel et al.
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Table 1. Characteristics of licensed pesticide appli-
cators enrolled in the AHS 1993–1997 (n = 18,782).a
Characteristic Percent
Age (years)
18–30 8
31–35 9
36–40 13
41–45 14
46–50 12
51–55 12
56–60 12
61–65 10
66–75 10
State
Iowa 70
North Carolina 30
Educationb
≤ High school 56
> High school 44
Cigarette smoking (lifetime pack-years)b
05 7
> 0–30 35
> 30 8
Alcohol use (any consumption in last year)b
No 34
Yes 66
aThe analysis was restricted to white men who provided a
response for each of 23 neurologic symptoms. bMissing
data (< 3%) were imputed on an age- and state-specific
basis for education, cigarette smoking, and alcohol use,
using medians of the relevant strata.
Table 2. Percentage of study participants experiencing the indicated frequency of neurologic symptoms in
the year before enrollment, among licensed pesticide applicators enrolled in the AHS 1993–1997 (n = 18,782).a
Symptom Never Once a year Once a month Once a week > Once a week
Headache 32 18 36 10* 4*
Fatigue 42 16 24 10 9*
Tension 48 16 22 9* 6*
Insomnia 57 10 19 8* 7*
Irritability 63 13 16 5* 3*
Dizziness 72 19 7* 1* 1*
Numbness in hands or feet 73 9 10 4* 5*
Depression 73 12 10* 3* 2*
Nausea 73 24 3* < 1* < 1*
Absentmindedness 76 7 9 4* 4*
Difﬁculty concentrating 80 7 7* 3* 2*
Loss of appetite 82 11 5* 1* < 1*
Excessive sweating 83 8 5* 2* 2*
Twitches in arms or legs 83 7 6* 2* 2*
Fast heart rate 85 7 5* 2* 1*
Weakness in arms or legs 85 6 5* 1* 2*
Poor balance 88 7 3* 1* 1*
Poor night vision 88 3 3* 1* 4*
Tremor in hands 89 5* 3* 1* 2*
Blurred/double vision 90 5* 3* 1* 1*
Changes in smell or taste 94 4* 1* < 1* < 1*
Difﬁculty speaking 96 2* 1* 1* 1*
Loss of consciousness 98 1* < 1* < 1* < 1*
aSymptoms are listed in order of decreasing frequency. Symptom distributions were dichotomized so that the positive
category included between 5 and 15% of participants. *Responses included in the positive (“case”) category. Neurologic symptoms in licensed pesticide applicators
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Table 3. Association of summary measures of neurologic symptom prevalence with pesticide use and exposure among licensed pesticide applicators enrolled in
the AHS 1993–1997 (n = 18,782).
Exposure Case (%) Control (%) Many symptomsa [OR (95% CI)] No. symptomsb [β (SE)]
Use of any pesticide
Cumulative lifetime days of use
0–64 23 25 1.00 (referent) 0 (referent)
65–200 22 21 1.16 (1.04–1.30) 0.45 (0.10)
201–396 27 26 1.14 (1.02–1.26) 0.47 (0.10)
397–7,000 28 27 1.20 (1.08–1.33) 0.60 (0.10)
Ever diagnosed with pesticide poisoning
No 96 98 1.00 (referent) 0 (referent)
Yes 4 2 2.46 (1.97–3.08) 2.58 (0.25)
Ever received medical attention for pesticide-related illness
No 89 95 1.00 (referent) 0 (referent)
Saw doctor only 9 4 2.25 (1.95–2.59) 2.07 (0.16)
Hospitalized 2 1 1.98 (1.43–2.74) 1.76 (0.35)
Ever had an event involving high personal exposure
No event 76 88 1.00 (referent) 0 (referent)
Yes, no internal exposurec 13 8 1.80 (1.60–2.02) 1.68 (0.12)
Yes, with internal exposurec 11 4 3.04 (2.65–3.49) 3.08 (0.15)
Cumulative pesticide use, functional categories
Insecticides (lifetime days, without or with use in past year)
0 days 5 9 1.00 (referent) 0 (referent)
1–50 days, no use in past year 14 15 1.64 (1.36–1.97) 1.25 (0.15)
1–50 days, used in past year 8 10 1.34 (1.09–1.63) 0.90 (0.17)
51–500 days, no use in past year 22 22 1.89 (1.58–2.25) 1.67 (0.14)
51–500 days, used in past year 32 31 1.82 (1.53–2.15) 1.72 (0.14)
> 500 days, no use in past year 6 5 2.50 (2.00–3.13) 2.34 (0.20)
> 500 days, used in past year 12 9 2.50 (2.06–3.03) 2.43 (0.17)
Herbicides (lifetime days, without or with use in past year)
0 days 2 3 1.00 (referent) 0 (referent)
1–50 days, no use in past year 5 5 1.04 (0.77–1.40) 0.57 (0.27)
1–50 days, used in past year 5 6 0.85 (0.63–1.15) 0.28 (0.26)
51–500 days, no use in past year 13 13 1.16 (0.89–1.52) 0.79 (0.24)
51–500 days, used in past year 36 36 1.11 (0.86–1.43) 0.80 (0.23)
> 500 days, no use in past year 7 7 1.32 (0.99–1.75) 1.10 (0.26)
> 500 days, used in past year 32 30 1.27 (0.98–1.64) 1.25 (0.23)
Fungicides (lifetime days, without or with use in past year)
0 days 69 71 1.00 (referent) 0 (referent)
1–50 days, no use in past year 12 10 1.31 (1.16–1.48) 0.94 (0.12)
1–50 days, used in past year 9 8 1.21 (1.05–1.39) 0.60 (0.13)
> 50 days, no use in past year 4 4 1.23 (1.00–1.50) 0.60 (0.19)
> 50 days, used in past year 8 7 1.24 (1.05–1.45) 0.67 (0.15)
Fumigants (lifetime days, without or with use in past year)
0 days 78 81 1.00 (referent) 0 (referent)
1–50 days, no use in past year 13 11 1.48 (1.31–1.66) 1.06 (0.11)
1–50 days, used in past year 3 3 1.16 (0.90–1.48) 0.19 (0.23)
> 50 days, no use in past year 5 4 1.50 (1.24–1.81) 0.99 (0.18)
> 50 days, used in past year 2 2 1.29 (0.98–1.71) 0.56 (0.27)
Cumulative insecticide use, chemical classes
Organophosphates (lifetime days, without or with use in past year)
0 days 9 14 1.00 (referent) 0 (referent)
1–50 days, no use in past year 20 21 1.39 (1.20–1.60) 1.00 (0.12)
1–50 days, used in past year 11 12 1.25 (1.06–1.46) 0.80 (0.14)
51–500 days, no use in past year 21 20 1.63 (1.41–1.88) 1.36 (0.12)
51–500 days, used in past year 29 27 1.59 (1.39–1.83) 1.47 (0.12)
> 500 days, no use in past year 4 3 2.16 (1.71–2.73) 1.91 (0.23)
> 500 days, used in past year 6 4 2.23 (1.84–2.71) 2.08 (0.19)
Organochlorines (lifetime days, without or with use in past year)
0 days 51 56 1.00 (referent) 0 (referent)
1–50 days, no use in past year 29 27 1.60 (1.45–1.75) 1.24 (0.09)
1–50 days, used in past year 1 1 1.04 (0.61–1.74) 0.74 (0.48)
> 50 days, no use in past year 18 16 2.00 (1.78–2.23) 1.76 (0.10)
> 50 days, used in past year 1 1 2.23 (1.51–3.31) 1.74 (0.42)
Carbamates (lifetime days, without or with use in past year)
0 days 40 45 1.00 (referent) 0 (referent)
1–50 days, no use in past year 29 26 1.42 (1.30–1.56) 1.02 (0.09)
1–50 days, used in past year 5 6 1.18 (1.00–1.40) 0.57 (0.16)
> 50 days, no use in past year 15 14 1.55 (1.38–1.75) 1.22 (0.11)
> 50 days, used in past year 10 10 1.48 (1.27–1.71) 1.15 (0.14)
Pyrethroids (lifetime days, without or with use in past year)
0 days 72 78 1.00 (referent) 0 (referent)
1–50 days, no use in past year 13 10 1.31 (1.17–1.47) 0.80 (0.12)
1–50 days, used in past year 6 5 1.16 (0.99–1.37) 0.61 (0.16)
> 50 days, no use in past year 4 3 1.24 (1.09–1.58) 0.86 (0.19)
> 50 days, used in past year 5 3 1.31 (1.09–1.58) 1.09 (0.19)
aProportion of applicators who experienced ≥ 10 versus < 10 speciﬁc symptoms in the year before enrollment. Results are expressed as odds ratio (OR) with 95% conﬁdence interval
(95% CI) from logistic regressions adjusted for age, state, education, cigarette smoking, and alcohol use. bNumber of speciﬁc symptoms experienced at least once in the year before
enrollment, used as a continuous variable. Results are expressed as estimates (SE) from linear regressions adjusted for age, state, education, cigarette smoking, and alcohol use.
cA high-pesticide-exposure event involving internal exposure was deﬁned as one involving inhalation or ingestion of pesticide.lowest quartile, with a weak dose–response
relation across quartiles. Individuals with a his-
tory of pesticide poisoning experienced more
symptoms than did those without such a
history (Table 3). Applicators who had ever
sought medical attention for pesticide-related
illness also experienced more symptoms than
those who had not (Table 3), even when indi-
viduals with a history of pesticide poisoning
were excluded (doctor visit: 2.1 times more
likely to have ≥ 10 symptoms and 1.8 more
symptoms). Experiencing a high-exposure
event was associated with an increased symp-
tom count, particularly when internal exposure
(inhalation or ingestion of pesticide) was
involved (Table 3). Again, similar results were
seen when individuals with a history of pesti-
cide poisoning were excluded (risk estimates
for internal exposure were unchanged).
Pesticides were grouped in functional
categories, and cumulative use (lifetime days)
and recent use (in the year before enrollment)
were evaluated simultaneously. Cumulative
use of insecticides was associated with both
measures of symptom count, with a pro-
nounced dose response (Table 3). Weaker
associations of symptoms with cumulative
herbicide, fungicide, and fumigant use were
observed. After accounting for cumulative
use, recent use was not associated with an
increased symptom count for any pesticide
category (Table 3). Associations with cumula-
tive use were similar in models not including
recent use (data not shown). When cumula-
tive use in all four functional categories was
assessed simultaneously, associations with
insecticides and fumigants were only slightly
reduced, but relationships with herbicides and
fungicides were no longer present; results
were similar whether or not recent use was
included in the models (data not shown).
Insecticides were further categorized by
chemical class, with cumulative and recent use
evaluated simultaneously. Greater symptom
count was associated with cumulative use in all
four chemical classes of insecticides (Table 3).
Associations were strongest for organophos-
phates and organochlorines; dose response for
cumulative use was evident for all classes except
pyrethroids. After accounting for cumulative
use, recent use was not associated with symp-
tom count for any chemical class (Table 3).
Associations with cumulative use were similar
in models not including recent use (data not
shown). When cumulative use in all four
chemical classes was considered simulta-
neously, associations with organophosphates,
organochlorines, and carbamates were still pre-
sent, although slightly attenuated, but the rela-
tionship with pyrethroids was present only for
number of symptoms and not for many symp-
toms; Results were similar whether or not
recent use was included in the models (data
not shown).
Associations with cumulative use of pesti-
cides in functional or chemical groups were not
affected by excluding individuals with diag-
nosed pesticide poisoning (n = 363) or those
who had experienced a high-exposure event
(n = 2,688). In models including cumulative
use of all four functional categories of pesti-
cides, applicators in the highest category of
insecticide use were 2.2–2.4 times as likely
to experience ≥ 10 symptoms and averaged
2.0–2.1 additional symptoms, regardless of
whether or not individuals with pesticide poi-
soning, a high-exposure event, or either were
excluded from the analysis. In models includ-
ing cumulative use in all four chemical classes
of insecticides, applicators in the highest cate-
gory of organophosphate use were 1.6–1.7
times as likely to experience ≥ 10 symptoms
and averaged 1.0–1.1 additional symptoms,
regardless of exclusions. Associations of symp-
toms with cumulative pesticide use were also
not affected by excluding individuals with self-
reported neurologic disease (n = 498), depres-
sion (n = 849), stroke (n = 113), head injury
(n = 2,307), myocardial infarction (n = 518),
or diabetes (n = 635); these were similar in
Iowa and North Carolina and were not
affected by adjusting for occupational exposure
to solvents or metals on or off the farm (data
not shown).
Specific symptoms were also related to
pesticide use. Symptoms were associated with
use of any pesticide, any insecticide, organo-
phosphates, organochlorines, or fumigants
(Table 4). Pesticide poisoning, pesticide-
related medical visits, and high-exposure
events were also associated with increases
in specific symptoms but did not alter the
observed associations with pesticide use (data
not shown). For any particular exposure meas-
ure, there was little variation in the magni-
tude of the associations among symptoms.
Similar results were found when symptoms
were grouped in categories deﬁned a priori to
reflect particular aspects of neurologic func-
tion, including affect, cognition, autonomic
function, motor function, and vision (data
not shown).
Discussion
In this study we found that increased symp-
tom count was associated with cumulative
lifetime use of pesticides, particularly insecti-
cides and fumigants. Increased symptom
count was also associated with a history of
pesticide poisoning or events involving high
personal pesticide exposure. Significantly,
however, associations with cumulative use
persisted even after excluding individuals with
a history of pesticide poisoning or high expo-
sure events. Recent pesticide use, within the
year before reporting symptoms, was not
related to symptom count after accounting
for cumulative exposure, and adjustment for
recent use did not affect the association of
cumulative use with symptom count.
Most previous studies of pesticides and
neurologic symptoms have focused on organo-
phosphates. Farm workers (Gomes et al. 1998;
Strong et al. 2004), greenhouse workers
Kamel et al.
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Table 4. Associations of speciﬁc neurologic symptoms with pesticide exposure among licensed pesticide
applicators enrolled in the AHS 1993–1997 (n = 18,782).
Any All Organo- Organo-
pesticide insecticides phosphates chlorines Fumigants
Headache 1.25* 1.80* 1.62* 1.31* 1.10
Fatigue 0.99 2.29* 2.34* 1.60* 1.10
Tension 1.22* 1.98* 1.82* 1.55* 1.30*
Insomnia 1.24* 1.78* 1.70* 1.56* 1.21
Irritability 1.16* 2.33* 1.93* 1.57* 1.46*
Dizziness 1.26* 2.34* 1.77* 1.66* 1.38*
Numbness in hands or feet 1.18* 2.64* 2.67* 1.75* 1.25*
Depression 1.19* 2.30* 2.09* 1.68* 1.31*
Nausea 1.11 1.93* 1.88* 1.59* 1.37
Absentmindedness 1.12 2.57* 2.13* 1.75* 1.24*
Difﬁculty concentrating 1.15* 2.27* 2.07* 1.84* 1.36*
Loss of appetite 1.14 1.80* 1.76* 1.51* 1.22
Excessive sweating 1.12 2.03* 1.84* 1.70* 1.10
Twitches in arms or legs 1.16* 2.65* 2.34* 1.68* 1.43*
Fast heart rate 1.22* 2.19* 1.95* 1.74* 1.23
Weakness in arms or legs 1.01 1.84* 1.82* 1.77* 1.03
Poor balance 1.20* 2.46* 1.77* 1.95* 1.40*
Poor night vision 1.24* 2.06* 1.85* 1.62* 1.38*
Tremor in hands 1.26* 2.20* 2.00* 1.68* 1.17
Blurred/double vision 1.25* 2.08* 1.87* 1.75* 1.29*
Changes in smell or taste 1.61* 2.11* 1.83* 2.12* 1.57*
Difﬁculty speaking 1.30* 2.25* 1.94* 1.97* 1.07
Loss of consciousness 1.49* 1.41 1.26 1.76* 1.34
Table entries are odds ratios for experiencing the symptom with high frequency compared with low frequency, using cut
points shown in Table 2. Odds ratios were calculated by logistic regression models with adjustment for age, state, educa-
tion, cigarette smoking, and alcohol use. Estimates are for the highest category of lifetime days of use of the indicated
pesticide groups.
*Estimates for which the 95% conﬁdence interval excluded 1.00.(Bazylewicz-Walczak et al. 1999), and factory
workers (Bellin and Chow 1974) exposed to
organophosphates reported more symptoms
than unexposed workers. Farmers and farm
workers who applied organophosphates had
higher symptom prevalence than did nonappli-
cators (London et al. 1998; Ohayo-Mitoko
et al. 2000; Smit et al. 2003), as did commer-
cial termiticide applicators (Steenland et al.
2000) and sheep dippers (Pilkington et al.
2001). Other studies have used the Proﬁle of
Mood States or other scales to evaluate changes
in mood, ﬁnding higher levels of tension, anxi-
ety, anger, and depression in workers exposed
to organophosphates (Bazylewicz-Walczak
et al. 1999; Levin et al. 1976; Steenland et al.
2000; Stokes et al. 1995). Most (Bellin and
Chow 1974; Gomes et al. 1998; Leng and
Lewalter 1999; Ohayo-Mitoko et al. 2000)
although not all (Ciesielski et al. 1994; Lee
et al. 2003) studies found increased symptom
prevalence associated with inhibition of ery-
throcyte acetylcholinesterase activity, a bio-
marker of recent organophosphate exposure.
Although poisoning by high exposures to
organochlorines, fungicides, and fumigants as
well as organophosphates is well documented,
and carbamates, pyrethroids, and herbicides
are also neurotoxic (Ecobichon 1996; Keifer
and Mahurin 1997), questions remain con-
cerning the effects of moderate exposure to
pesticides other than organophosphates. One
study of moderate exposure found that
dichlorodiphenyltrichoroethane (DDT) was
associated with increased symptom prevalence
(van Wendel de Joode et al. 2001), as did one
study of fumigants (Anger et al. 1986), but
not another (Calvert et al. 1998). We found
that symptom count was related to all classes
of pesticides examined, although associations
with herbicides and fungicides appeared to
be due to confounding by insecticide use.
Organophosphate, carbamate, and organo-
chlorine insecticides were independently
associated with increased risk. The relative
neurotoxicity of speciﬁc chemicals or chemi-
cal classes may differ for acute high-level and
chronic moderate exposure. For example, the
stronger effects that we observed for organo-
chlorines may be related to their long biologic
half-lives (Ecobichon 1996).
Few previous studies were able to distin-
guish between effects of acute and chronic
exposure because the two are often correlated.
Two studies with sufficient information to
make the distinction found that in farmwork-
ers who applied pesticides increased symptom
prevalence was associated with acute but not
chronic exposure (London et al. 1998; Ohayo-
Mitoko et al. 2000). In contrast, our results
suggest that at moderate levels cumulative life-
time exposure has a greater impact on symp-
tom prevalence than exposure during the year
before reporting symptoms. This disparity may
be due to the higher level of exposure experi-
enced by farm workers compared with licensed
applicators.
The role of pesticide poisoning in the
apparent effects of cumulative use is still a
question. We conﬁrmed previous reports that a
history of pesticide poisoning is associated with
increased symptom prevalence (Kamel and
Hoppin 2004). A notable ﬁnding in our study
is that a history of events involving high per-
sonal pesticide exposure conferred equally great
risk, even in the absence of diagnosed poison-
ing. Some studies have not differentiated
exposed individuals with a history of pesticide
poisoning from those without. Two studies
that excluded poisoned individuals found no
relationship of moderate organophosphate
exposure to symptom prevalence (Ames et al.
1995; Fiedler et al. 1997), although a study
of DDT that excluded poisoned individuals
did ﬁnd an association (van Wendel de Joode
et al. 2001). We found dose-related asso-
ciations of symptom count to cumulative
exposure to all insecticides, organophos-
phates, and organochlorines whether or not
we excluded individuals with a history of pes-
ticide poisoning or those who had experi-
enced high-exposure events, indicating that
moderate exposure itself is associated with
increased risk.
Our findings were similar regardless of
whether we considered summary measures of
all symptoms, individual symptoms, or symp-
tom groups deﬁned a priori. These results are
consistent with previous studies suggesting
that moderate pesticide exposure is associated
with a wide range of symptoms, reﬂecting cog-
nitive, sensory, and motor dysfunction and
affecting both the central and peripheral ner-
vous systems (Kamel and Hoppin 2004).
Pesticide exposure may be associated with
some fundamental disorder, such as depres-
sion or neurologic disease, which then inﬂu-
ences the experience or perhaps the reporting
of multiple symptoms. Similarly, confounding
by head injury, which was related to pesticide
exposure in the AHS cohort, might explain
some of the increase in symptoms. However,
our findings were not affected by excluding
individuals with depression, neurologic dis-
ease, or head injury. The earliest manifestation
of neurotoxicity after moderate pesticide expo-
sure may in fact be an increase in many symp-
toms, not restricted to particular aspects of
neurologic function. A similar increase in a
wide range of symptoms is associated with sol-
vent exposure in mild cases of chronic solvent-
related toxic encephalopathy (van der Hoek
et al. 2000; White and Proctor 1997).
Confounding by demographic factors
does not appear to explain our results. There
was a strong inverse association of symptom
prevalence with age. The basis of this associa-
tion is unclear; it may represent participants’
understanding of the symptom questions or
reporting proclivities rather than a real rela-
tionship. Other explanations are possible.
Symptomatic individuals may have left farm-
ing at an early age and thus never entered our
cohort, representing a type of healthy worker
effect. Younger applicators used more pesti-
cides in the year before enrollment, the period
for which symptom prevalence was reported;
however, adjusting for recent use did not
affect associations with cumulative use. In any
case, because symptom prevalence decreased
and cumulative exposure increased with age,
confounding by age or age-related conditions
like heart disease or diabetes cannot explain
the positive associations we observed with
cumulative exposure; moreover, excluding
individuals with the latter conditions did not
affect our results. This point is particularly
important in interpreting results for organo-
chlorine pesticides. Secular trends in use
mean that older applicators are more likely to
have used these chemicals, but this cannot
account for the association with symptoms
because age was inversely related to symptom
count. We adjusted for other potential con-
founders, including education, so these are
also unlikely to account for our results. We
had no information on personality traits that
may have affected symptom reporting, and
so could not adjust for these, but they are
unlikely to have covaried with exposure, par-
ticularly in a way that could account for the
dose–response relationships we observed.
Potential bias is also a concern. The present
analysis was based on the subset of private
applicators who completed the take-home
questionnaire. Although these are only 44% of
the private applicators enrolled in the AHS,
they are clearly representative of the cohort as a
whole: Applicators who did or did not com-
plete the take-home questionnaire were similar
for every lifestyle or demographic characteristic
except age; for health outcomes, including
experience of pesticide-related health symp-
toms; and for farm characteristics and tasks
and a variety of measures of pesticide exposure
(Tarone et al. 1997). These results mitigate
concerns regarding selection bias. Because
symptoms were self-reported, another concern
is potential recall or reporting bias. However,
the fact that only some pesticides were associ-
ated with symptoms suggests that recall bias
does not account for our ﬁndings. Risks associ-
ated with insecticide exposure were dose-
related, further suggesting that bias does not
explain our results. Moreover, our ﬁndings are
biologically plausible, because we found the
greatest risk for insecticides, which are designed
to be neurotoxicants.
An important strength of our study is its
large size. Further, because farming practices
are considerably different in Iowa and North
Carolina, the AHS cohort represents a diverse
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1999a). We used internal comparisons of more
and less exposed individuals from the same
population, thereby reducing potential con-
founding. The primary strength of the study is,
however, the availability of detailed exposure
information. Although the present analysis is
limited by its cross-sectional design, data on
symptoms and pesticide exposure were col-
lected in separate portions of the question-
naires, some completed at different times,
minimizing potential bias. Exposure data were
reported by the applicators themselves, but
farmers in general and AHS cohort members
in particular report pesticide use reliably (Blair
et al. 2002; Hoppin et al. 2002).
In conclusion, we found that prevalence of
neurologic symptoms was associated with
cumulative lifetime exposure to pesticides, par-
ticularly organophosphate and organochlorine
insecticides and fumigants. These associations
were present in individuals with no history of
pesticide poisoning or high exposure events
and were independent of recent exposure.
Thus, they are likely due to chronic moderate
exposure. Although the neurotoxicity of high-
level exposure is accepted, more attention to
the risks associated with moderate exposure
may be required.
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